# Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

> **NCT03744585** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 450 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03744585
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-06
- **Primary completion:** 2019-06-07
- **Final completion:** 2019-07-07
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2019-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03744585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03744585, "Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03744585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*